Carvolix strengthens its governance bodies

Carvolix, a French medical technology company, announces a major reshuffle within its Board of Directors and Advisory Board. Anne Lange joins the Board, replacing Soad El Gazaoui, while Rute Fernandes is appointed Censor. Scientific leadership is also strengthened with the arrival of Paul LaViolette and Dr. Mirvat Alasnag.

Liane Teplitsky remains president, with Michel Therin serving as vice-president. These changes are intended to support Carvolix's ambitious development plan, which positions the company as a leader in Europe and sixth worldwide according to the Truffle Medtech 10 index.

These appointments demonstrate Carvolix's commitment to strengthening its expertise to support its innovations in mini-robots and biometric implants for cardiologists.